Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers von Golan, T, Kanji, Z S, Epelbaum, R, Devaud, N, Dagan, E, Holter, S, Aderka, D, Paluch-Shimon, S, Kaufman, B, Gershoni-Baruch, R, Hedley, D, Moore, M J, Friedman, E, Gallinger, S

Volltext

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up von Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, A., Seufferlein, T., O’Reilly, E.M., Hackert, T., Golan, T., Prager, G., Haustermans, K., Vogel, A., Ducreux, M.

Volltext

First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer von Niu, J., Maurice-Dror, C., Lee, D.H., Kim, D.-W., Nagrial, A., Voskoboynik, M., Chung, H.C., Mileham, K., Vaishampayan, U., Rasco, D., Golan, T., Bauer, T.M., Jimeno, A., Chung, V., Chartash, E., Lala, M., Chen, Q., Healy, J.A., Ahn, M.-J.

Volltext

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine von Casolino, R., Braconi, C., Malleo, G., Paiella, S., Bassi, C., Milella, M., Dreyer, S.B., Froeling, F.E.M., Chang, D.K., Biankin, A.V., Golan, T.

Volltext

Ignition’s glow: Ultra-fast spread of global cortical activity accompanying local “ignitions” in visual cortex during conscious visual perception von Noy, N., Bickel, S., Zion-Golumbic, E., Harel, M., Golan, T., Davidesco, I., Schevon, C.A., McKhann, G.M., Goodman, R.R., Schroeder, C.E., Mehta, A.D., Malach, R.

Volltext

Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro)... von Harrington, K.J., Brody, J., Ingham, M., Strauss, J., Cemerski, S., Wang, M., Tse, A., Khilnani, A., Marabelle, A., Golan, T.

Volltext

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibit... von Brana, I, Berger, R, Golan, T, Haluska, P, Edenfield, J, Fiorica, J, Stephenson, J, Martin, L P, Westin, S, Hanjani, P, Jones, M B, Almhanna, K, Wenham, R M, Sullivan, D M, Dalton, W S, Gunchenko, A, Cheng, J D, Siu, L L, Gray, J E

Volltext

A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer von Garralda, E., Sukari, A., Lakhani, N.J., Patnaik, A., Lou, Y., Im, S.-A., Golan, T., Geva, R., Wermke, M., de Miguel, M., Palcza, J., Jha, S., Chaney, M., Abraham, A.K., Healy, J., Falchook, G.S.

Volltext

Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial von Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M., Park, J., Hochhauser, D., Arnold, D., Oh, D., Reinacher-Schick, A., Tortora, G., Algül, H., O’Reilly, E., McGuinness, D., Cui, K., Schlienger, K., Locker, G., Kindler, H.

Volltext

Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine von Golan, T, Atias, D, Barshack, I, Avivi, C, Goldstein, R S, Berger, R

Volltext

Evaluation of a possible link between immunotherapy (IO) and acute vascular events von Bar, J., Shulman, K., Kuznetsov, T., Markel, G., Daher, S., Berger, R., Golan, T., Urban, D., Sela, T., Shacham Shmueli, E., Klempfner, R., Talianski, A., Onn, A., Dudnik, E.

Volltext

The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation von Tavor, S, Eisenbach, M, Jacob-Hirsch, J, Golan, T, Petit, I, BenZion, K, Kay, S, Baron, S, Amariglio, N, Deutsch, V, Naparstek, E, Rechavi, G

Volltext

Reducing model bias in a deep learning classifier using domain adversarial neural networks in the MINERvA experiment von Perdue, G N, Ghosh, A, Wospakrik, M, Akbar, F, Andrade, DA, Ascencio, M, Bellantoni, L, Bercellie, A, Betancourt, M, G F R Caceres Vera, Cai, T, Carneiro, M F, Chaves, J, Coplowe, D, da Motta, H, Díaz, G A, Felix, J, Fields, L, Fine, R, Gago, A M, Galindo, R, Golan, T, Gran, R, Han, J Y, Harris, D A, Jena, D, Kleykamp, J, Kordosky, M, Lu, X-G, Maher, E, Mann, W A, Marshall, C M, McFarland, K S, McGowan, A M, Messerly, B, Miller, J, Nelson, J K, Nguyen, C, Norrick, A, Nuruzzaman, Olivier, A, Patton, R, Ramírez, MA, Ransome, R D, Ray, H, Ren, L, Rimal, D, Ruterbories, D, Schellman, H, Solano Salinas, C J, H Su, Upadhyay, S, Valencia, E, Wolcott, J, Yaeggy, B, Young, S

Volltext

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing von Paiella, S., Azzolina, D., Gregori, D., Malleo, G., Golan, T., Simeone, D.M., Davis, M.B., Vacca, P.G., Crovetto, A., Bassi, C., Salvia, R., Biankin, A.V., Casolino, R.

Volltext

Enhancing susceptibility to PARPi in homologous recombination repair dysfunction (HRD)-associated pancreatic cancer von Golan, T, Buzhor, E, Halparin, S, Cohen, K, Atias, D, Stossel, C, Raitses-Gurevich, M, Berger, R

Volltext

A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC) von Hidalgo, M., Epelbaum, R., Wolpin, B.M., Stemmer, S.M., Geva, R., Golan, T., Borazanci, E., Borad, M., Pedersen, K.S., Park, J.O., Ramirez, R., Peled, A., Lustig, T.M., Bohana Kashtan, O., Rosenfeld, O., Sorani, E., Schlienger, K., Vainstein Haras, A., Von Hoff, D.D.

Volltext

Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations von Halpern, N., Grinshpun, A., Boursi, B., Golan, T., Margalit, O., Aderka, D., Laitman, Y., Friedman, E., Hubert, A., Peretz, T., Hamburger, T., Kedar-Barnes, I., Levi, Z., Ben-Aharon, I., Goldberg, Y., Shacham-Shmueli, E.

Volltext

P-146Colorectal cancer patients with lung-only metastases have a favorable prognosis irrespective of treatment von Gadot, M, Lawrence, Y, Aderka, D, Golan, T, Shani, A, Halpern, N, Margalit, O, Shmueli, E

Volltext

Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey von Alvarez, E., Nair, K.V., Gorritz, M., Bartolome, L., Maloney, H., Ding, Y., Golan, T., Wade, R.L., Kumar, R., Su, W., Shah, R., Russo, P.

Volltext

Low‐dose cyclosporin A in the treatment of severe chronic idiopathic urticaria von Toubi, E., Blant, A., Kessel, A., Golan, T. D.

Volltext